Evidence map›Paper›PMID 41313553›Full record

ArticleEJNMMI research2025

Global and regional accuracy of deep learning-based tumor segmentation from whole-body [

Andrea Ciarmiello, Nikola Yosifov, Donatella Masciale, Ornella Ferrando, Franca Foppiano, Amalia Milano, Massimo Canevari, Luigia Florimonte, Massimo Castellani, Giampiero Giovacchini and 2 more

Abstract read
In one paragraph

Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea CiarmielloNuclear Medicine Department, S. Andrea Hospital, La Spezia, Italy. ciarmiello@yahoo.com.ORCID http://orcid.org/0000-0002-6579-656X
Nikola YosifovNuclear Medicine Department, S. Andrea Hospital, La Spezia, Italy.
Donatella MascialeNuclear Medicine Department, S. Andrea Hospital, La Spezia, Italy.
Ornella FerrandoMedical Physics Department, S. Andrea Hospital, La Spezia, Italy.
Franca FoppianoMedical Physics Department, S. Andrea Hospital, La Spezia, Italy.
Amalia MilanoOncology Unit, S. Andrea Hospital, La Spezia, Italy.
Massimo CanevariBiomedical Engineering Department, S. Andrea Hospital, La Spezia, Italy.
Luigia FlorimonteNuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Massimo CastellaniNuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giampiero GiovacchiniNuclear Medicine Department, S. Andrea Hospital, La Spezia, Italy.
Lorenzo Stefano MaffioliIRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Bruno AlfanoHuman Shape Technologies, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of [¹⁸F]fluorodeoxyglucose ([¹⁸F]FDG)-PET/CT scans performed has significantly increased in the last decade in line with the increasing trend of oncological malignancies. Such images, which signal high glucose-uptake areas are key in defining the extent of the disease, staging and response to therapy. Processing and evaluation of ([¹⁸F]FDG)-PET/CT scans, however, require manual annotation by well-trained specialists and above all time. In time and resource-constrained settings meeting the increasing demand for PET/CT scans has become challenging. The main goal of our study was to test the relationship between the volumes predicted by the deep learning algorithm and the manually segmented ones. The secondary objective goal was to measure the extent at which the predictive accuracy is associated with normal background uptake.

resultsThe study sample included 1334 [¹⁸F]FDG-PET/CT scans from subjects with histologically confirmed diagnoses of lung cancer, lymphoma, and melanoma. 933 (70%) [¹⁸F]FDG-PET/CT scans were used as the training dataset and 267 (20%) scans were used as an internal validation dataset. A subsample of 134 (10%) [¹⁸F]FDG-PET/CT scans not used for training was used as the test dataset. The segmentation model was implemented with the nnU-Net convolutional network available in the MONAI framework. Model performance was measured with the Dice score. Correlation between manual and predicted segmentation was assessed using linear correlation. Totalsegmentator tool was used to identify lesions location and assess the tumor-to-background ratio (TBR) for quantitative analysis. Network achieved Dice scores of 0.918 (validation) and 0.879 (test), showing strong agreement with manual segmentations. The model achieved an F1 score of 0.91 on the test set. High correlation (R=0.82, p<0.0001) was observed between predicted and ground truth volumes. Segmentation accuracy improved with higher TBRs, as lesions with TBR>2 had significantly better Dice scores than those with lower contrast (TBR ≤ 1-2 or≤1).

conclusionsThese results are consistent with previous reports on PET-based segmentation, further validating nnU-Net as a reliable approach for detecting hypermetabolic lesions and assessing global disease burden in FDG-PET imaging. Moreover, the significant relationship between TBR and segmentation accuracy suggests the possibility of further improvements by integrating metabolic profile into the predictive model.

Indexed as

18F-FDG PET/CTDeep learningNnU -NetSegmentation

Identifiers

PMID41313553
PMCPMC12764704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.